#United States #Medical Devices #Aliso Viejo #Okami Medical #Bill Hoffman

Okami Medical Aims for Growth with New Board Member

In a significant move aimed at enhancing its leadership, Okami Medical has announced the appointment of Bill Hoffman to its Board of Directors. This decision reflects the company's commitment to bolster its strategic direction with experienced professionals in the medical device industry.

Bill Hoffman joins Okami Medical with an impressive track record. As a Venture Partner at Vensana Capital, he has been instrumental in guiding several medical technology companies toward success. His prior experience includes serving as CEO of Inari Medical from 2015 to 2022, during which he led the company through a successful initial public offering (IPO) and established it as a leader in treating venous thromboembolism. Hoffman's journey also includes prominent roles at Visualase, which was acquired by Medtronic in 2014, and FoxHollow Technologies, acquired by ev3 in 2007.

A Vision for Operational Excellence

Rhonda Robb, President and CEO of Okami Medical, emphasized the importance of Hoffman's addition to the board, stating, "We are thrilled to welcome Bill to our Board of Directors. He brings extensive experience in the medical device industry and is an exceptionally strong leader with a track record of driving growth while creating a culture of operational excellence." This sentiment shows the company's focus on not just growth, but also on maintaining high standards operationally and culturally.

Hoffman expressed his enthusiasm about joining Okami Medical by stating, "I'm honored to join the Okami team and have been impressed by the performance of the LOBO vascular occluder in a wide variety of anatomies. I look forward to working with the team to expand our commercial launch and make this important technology available to more physicians and patients." His commitment to ensuring greater accessibility to innovative medical solutions aligns perfectly with Okami's goals.

Okami Medical’s Mission and Vision

Established in 2017, Okami Medical aims to respond to the changing needs of patients and healthcare providers through innovative and intuitive medical devices. The company focuses on the occlusion of peripheral vessels, ensuring a blend of versatility and user-friendliness in its products. Leveraging the expertise of its board members, including affiliations with notable investors such as Vensana Capital and U.S. Venture Partners (USVP), Okami has set out to make a significant impact on the medical device landscape.

Notably, the team behind Okami Medical comes from a successful background in the medical device sector, having previously developed companies like Inari Medical, Sequent Medical, and MicroVention, both of which were acquired by Terumo. These achievements underline Okami’s potencial to innovate and lead within its niche market.

As the medical community eagerly anticipates the developments that Hoffman's appointment will bring, Okami Medical stands poised to not only grow its product line but also enhance the quality of care available to patients. The addition of Bill Hoffman reinforces a proactive approach to leadership and growth strategy, ensuring that Okami Medical remains at the forefront of medical device innovation.

For more information, visit Okami Medical's website.